On March 4, 2024, NewGLAB Pharma CO.,LTD closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,383 KRW | -27.44% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 47.05M | |
+26.16% | 2.01B | |
-15.40% | 1.11B | |
+75.54% | 875M | |
+10.96% | 818M | |
-9.74% | 778M | |
+44.37% | 673M | |
-26.82% | 373M | |
-9.46% | 289M | |
+27.76% | 165M |
- Stock Market
- Equities
- A214870 Stock
- News NewGLAB Pharma CO.,LTD
- NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors